Press Releases - EQL Pharma

EQL Pharma AB

Investor Relations Contact

Svenska

Press Release
Regulatory
Bulletin from the annual general meeting in EQL Pharma AB on 20 August 2026
2026-08-20
Press Release
Memprex© (methenamine hippurate) license signed with partner for Hungary
2026-08-12
Press Release
Regulatory
Interim Report April - June 2026
2026-08-07
Press Release
Regulatory
EQL Pharma recruits Oskar Karmlid as new Chief Supply Chain Officer (CSCO)
2026-07-27
Press Release
Regulatory
EQL Pharma Annual Report 2025/2026
2026-07-24
Press Release
Regulatory
Notice of annual general meeting in EQL Pharma AB
2026-07-17
Press Release
Mellozzan® (melatonin) approved in Kazakhstan
2026-07-15
Press Release
Memprex© (methenamine hippurate) license signed with partner for Spain
2026-07-13
Press Release
Invitation to presentation in connection with EQL Pharma's interim report, first quarter, 2026/27
2026-07-10